电话:
400-7060-959
传真:
+86 10 56315212-8813
电子邮件:
orders@antibodies-online.cn

FLT4 抗体

(Fms-Related Tyrosine Kinase 4 (FLT4))
This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA. [provided by RefSeq, Jul 2008].
FLT4 抗体  (AA 25-259) FLT4 抗体  (AA 25-259) FLT4 抗体 (AA 25-259) (ABIN5693136)

FLT4 适用: 人, 小鼠, 大鼠 WB, IHC, ELISA 宿主: 兔 Polyclonal unconjugated

FLT4 抗体  (AA 1174-1363) FLT4 抗体  (AA 1174-1363) FLT4 抗体 (AA 1174-1363) (ABIN6140699)

FLT4 适用: 人 IHC, IF 宿主: 兔 Polyclonal unconjugated

FLT4 抗体  (AA 1-439) FLT4 抗体  (AA 1-439) FLT4 抗体 (AA 1-439) (ABIN1882290)

FLT4 适用: 人 WB, FACS, IHC (p) 宿主: 小鼠 Monoclonal 818CT12-1-1 unconjugated

FLT4 抗体 by 适用

Find FLT4 抗体 for a variety of species such as anti-Human FLT4, anti-Mouse FLT4, anti-Cow FLT4. The species listed below are among those available. Click on a link to go to the corresponding products.

FLT4 抗体 by 应用范围

Find FLT4 抗体 validated for a specific application such as WB, ELISA, IHC, FACS. Some of the available applications are listed below. Click on a link to go to the corresponding products.

FLT4 抗体 by 抗体来源

Find FLT4 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.

FLT4 抗体 by 抗原表位

Find FLT4 抗体 with a specific epitope. The epitopes listed below are among those available. Click on a link to go to the corresponding products.

FLT4 抗体 by 克隆形成能力

Find available monoclonal or polyclonal FLT4 抗体. Click on a link to go to the corresponding products.

FLT4 抗体 by 克隆

Find FLT4 抗体 with a specific 克隆. The 克隆 listed below are among those available. Click on a link to go to the corresponding products.

FLT4 抗体 by 标记

Find FLT4 抗体 with a specific conjugate such as Biotin, FITC, APC. The conjugates listed below are among those available. Click on a link to go to the corresponding products.

Popular FLT4 抗体

Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity Human, Mouse, Rat
Application WB, IHC, ELISA
Validations
  • (1)
  • (7)
Cat. No. ABIN5693136
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application IHC, IF
Validations
  • (1)
  • (4)
Cat. No. ABIN6140699
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application WB, FACS, IHC (p)
Validations
  • (5)
  • (5)
Cat. No. ABIN1882290
Quantity 400 μL
Datasheet Datasheet
Reactivity Human
Application WB, IHC, ELISA, FACS
Validations
  • (8)
Cat. No. ABIN3030977
Quantity 0.4 mL
Datasheet Datasheet
Reactivity Cow, Human, Mouse
Application ELISA, FACS, IHC (p), IF (cc), IF (p), IHC (fro), ICC
Validations
  • (3)
  • (3)
Cat. No. ABIN678578
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application IHC, ELISA
Validations
  • (4)
Cat. No. ABIN7189527
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application WB, ELISA
Validations
  • (4)
Cat. No. ABIN560929
Quantity 100 μg
Datasheet Datasheet
Reactivity Human, Mouse
Application IHC, IF
Validations
  • (3)
Cat. No. ABIN7261548
Quantity 200 μL
Datasheet Datasheet
Reactivity Human
Application IHC (p)
Validations
  • (2)
Cat. No. ABIN4915123
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application WB, IHC, ELISA
Validations
  • (2)
Cat. No. ABIN7189520
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application IHC, ELISA, IF
Validations
  • (2)
Cat. No. ABIN7175388
Quantity 100 μg
Datasheet Datasheet
Reactivity Human, Mouse
Application WB, IHC, FACS, IHC (p), IP, IHC (fro)
Validations
  • (2)
Cat. No. ABIN957559
Quantity 50 μg
Datasheet Datasheet
Reactivity Human
Application WB, ELISA
Validations
  • (2)
Cat. No. ABIN560931
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application WB, ELISA
Validations
  • (2)
Cat. No. ABIN560926
Quantity 100 μg
Datasheet Datasheet
Reactivity Human, Rat
Application WB, IF
Validations
  • (2)
Cat. No. ABIN7256810
Quantity 200 μL
Datasheet Datasheet

Latest Publications for our FLT4 抗体

Zarjou, Black, Bolisetty, Traylor, Bowhay, Zhang, Harris, Agarwal: "Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease." in: Laboratory investigation; a journal of technical methods and pathology, (2019) (PubMed).

Norman, Gower, Chen, Fine: "Transcriptional landscape of pulmonary lymphatic endothelial cells during fetal gestation." in: PLoS ONE, Vol. 14, Issue 5, pp. e0216795, (2019) (PubMed).

Reed, Wang, Sonett, Chen, Yang, Li, Aradi, Jakus, DArmiento, Hancock, Kahn: "Lymphatic impairment leads to pulmonary tertiary lymphoid organ formation and alveolar damage." in: The Journal of clinical investigation, Vol. 129, Issue 6, pp. 2514-2526, (2019) (PubMed).

Durré, Morfoisse, Erpicum, Ebroin, Blacher, García-Caballero, Deroanne, Louis, Balsat, Van de Velde, Kaijalainen, Kridelka, Engelholm, Struman, Alitalo, Behrendt, Paupert, Noel: "uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis." in: Nature communications, Vol. 9, Issue 1, pp. 5178, (2019) (PubMed).

Jang, Choi, Park, Park, Choe, Kim, Kim, Lee, Hirashima, Kubota, Park, Cheng, Nagy, Park, Alitalo, Shong, Koh: "VEGFR2 but not VEGFR3 governs integrity and remodeling of thyroid angiofollicular unit in normal state and during goitrogenesis." in: EMBO molecular medicine, Vol. 9, Issue 6, pp. 750-769, (2018) (PubMed).

Song, Park, Ko, Park, Yoon, Kim, Kim, Kim, Lee, Prockop, Oh: "Mesenchymal Stromal Cells Inhibit Inflammatory Lymphangiogenesis in the Cornea by Suppressing Macrophage in a TSG-6-Dependent Manner." in: Molecular therapy : the journal of the American Society of Gene Therapy, Vol. 26, Issue 1, pp. 162-172, (2018) (PubMed).

Zhang, Ulvmar, Stanczuk, Martinez-Corral, Frye, Alitalo, Mäkinen: "Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms." in: Nature communications, Vol. 9, Issue 1, pp. 1296, (2018) (PubMed).

Frye, Taddei, Dierkes, Martinez-Corral, Fielden, Ortsäter, Kazenwadel, Calado, Ostergaard, Salminen, He, Harvey, Kiefer, Mäkinen: "Matrix stiffness controls lymphatic vessel formation through regulation of a GATA2-dependent transcriptional program." in: Nature communications, Vol. 9, Issue 1, pp. 1511, (2018) (PubMed).

Thomson, van de Pavert, Stakenborg, Labeeuw, Matteoli, Mowat, Nibbs: "Expression of the Atypical Chemokine Receptor ACKR4 Identifies a Novel Population of Intestinal Submucosal Fibroblasts That Preferentially Expresses Endothelial Cell Regulators." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 201, Issue 1, pp. 215-229, (2018) (PubMed).

Gauvrit, Villasenor, Strilic, Kitchen, Collins, Marín-Juez, Guenther, Maischein, Fukuda, Canham, Brickman, Bogue, Jayaraman, Stainier: "HHEX is a transcriptional regulator of the VEGFC/FLT4/PROX1 signaling axis during vascular development." in: Nature communications, Vol. 9, Issue 1, pp. 2704, (2018) (PubMed).

Aliases for FLT4 抗体

fms related tyrosine kinase 4 (FLT4) 抗体
FMS-like tyrosine kinase 4 (Flt4) 抗体
fms-related tyrosine kinase 4 (Flt4) 抗体
fms-related tyrosine kinase 4 (flt4) 抗体
AI323512 抗体
cb1059 抗体
Chy 抗体
Flt-4 抗体
FLT41 抗体
LMPH1A 抗体
PCL 抗体
VEGFR-3 抗体
VEGFR3 抗体
Vegfr3 抗体
You are here:
客服